Favourites   Have ideas?  Sign in / Register

Positive:   Cannabis ↓10.68   Biology ↓9.48   Food ↓7.71 «See more»   Pain fight ↑7.16   Country: Greate Britain ↑7.65   Country: Canada ↑40.52

Negative:   Bad infrastructure  ↓3.13


Cancer fight segment

ACET Adicet Bio, Inc. - Common Stock -5.68% up -7.22% 1.54 + Medicine, Cancer fight

+ My List
ADAP Adaptimmune Therapeutics plc - American Depositary Shares 8.27% up 7.73% 0.54 + Medicine, Cancer fight


Last highlighted: #ADAP SEC report: Adaptimmune Therapeutics PLC Statement of changes in beneficial ownership of securities
+ My List
AEMD Aethlon Medical, Inc. - Common Stock -3.63% up -7.92% 4.29 + Health Devices, Medicine, Cancer fight

+ My List
AFMD Affimed N.V. - Common Stock -7.12% down -5.43% -1.69 + Immunology, Cancer fight, Medicine

+ My List
AGEN Agenus Inc. - Common Stock -4.95% up -7.38% 2.43 + Cancer fight, Immunology, Medicine


Last highlighted: #AGEN SEC report: AGENUS INC Statement of changes in beneficial ownership of securities
+ My List
AIKI AIkido Pharma Inc. - Common Stock -6.8% up -8.74% 1.94 + Cancer fight, Pharmaceutical , Medicine


Last highlighted: #AIKI SEC report: AIkido Pharma Inc. Current report, item 8.01
SEC Filing Form 8-K filed by AIkido Pharma Inc. -- SEC File Number 211098058
+ My List
AKER Akers Biosciences Inc. - Common Stock -11% -11% 0 + Medicine, Pharmaceutical , Immunology, Cancer fight

+ My List
ALLO Allogene Therapeutics, Inc. - Common Stock 12.04% 12.04% 0 + Cancer fight, Gene and cell, Medicine

+ My List
ALPN Alpine Immune Sciences, Inc. - Common Stock 11.58% 11.58% 0 + Medicine, Cancer fight

+ My List
ALRN Aileron Therapeutics, Inc. - Common Stock -6.84% up -7.69% 0.85 + Cancer fight, Medicine, Biopharma

+ My List
ALXO ALX Oncology Holdings Inc. - Common Stock 5.32% up -7.69% 13.01 + Medicine, Cancer fight

+ My List
ANAB AnaptysBio, Inc. - Common Stock -0.76% up -7.46% 6.7 + Immunology, Cancer fight, Medicine

+ My List
ANCN Anchiano Therapeutics Ltd. - American Depositary Shares 0.00% 0 + Cancer fight, Biopharma, Medicine, Country: Israel

+ My List
ANIX Anixa Biosciences, Inc. - Common Stock -4.35% down 10.65% -15 + Cancer fight, Medicine, Immunology

+ My List
ANPC AnPac Bio-Medical Science Co., Ltd. - American Depositary Shares -2.50% -2.50% 0 + Cancer fight


Last highlighted: #ANPC SEC report: AnPac Bio-Medical Science Co., Ltd. [Amend] Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
SEC Filing Form 20-F/A filed by AnPac Bio-Medical Science Co., Ltd. -- SEC File Number 211081601
+ My List
APOP Cellect Biotechnology Ltd. - American Depositary Shares 7.92% up 6.97% 0.95 + Country: Israel, Cancer fight, Medicine

+ My List
APRE Aprea Therapeutics, Inc. - Common Stock -6.81% up -8.6% 1.79 + Medicine, Cancer fight


Last highlighted: Aprea Therapeutics Inc trading halted, news pending $APRE
+ My List
ARAV Aravive, Inc. - Common Stock 8.99% 8.99% 0 + Medicine, Cancer fight

+ My List
ATNX Athenex, Inc. - Common Stock 6.60% 6.60% 0 + Cancer fight, Biopharma, Covid (fighting)


Last highlighted: $ATNX 📜 SEC Form 10-Q filed by Athenex, Inc. https://t.co/1k3SCVGjG9 30 seconds delayed.
+ My List
AUTL Autolus Therapeutics plc - American Depositary Shares 7.32% up 5.2% 2.12 + Country: Greate Britain, Gene and cell, Cancer fight, Medicine


Last highlighted: $AUTL Autolus Therapeutics to Report First Quarter 2021 Financial Results and Host Conference Call on May 6 https://t.co/Bswi1mwqgf
+ My List
AVCO Avalon GloboCare Corp. - Common Stock up -15.24% 15.24 + Cancer fight, Medicine, Immunology, Pharmaceutical


Last highlighted: #AVCO SEC report: Avalon GloboCare Corp. Current report, items 1.01 and 9.01
SEC Filing Form 8-K filed by Avalon GloboCare Corp. -- SEC File Number 211089336
+ My List
AVEO AVEO Pharmaceuticals, Inc. - Common Stock -5.58% up -7.21% 1.63 + Medicine, Disease: Oncology, Cancer fight


Last highlighted: #AVEO SEC report: AVEO PHARMACEUTICALS, INC. Current report, items 2.02 and 9.01
SEC Filing Form 8-K filed by AVEO PHARMACEUTICALS, INC. -- SEC File Number 211148137
+ My List
AWH Aspira Women's Health Inc. - Common Stock -2.84% up -7.09% 4.25 + Cancer fight, Women Health, Medicine

+ My List
AYLA Ayala Pharmaceuticals, Inc. - Common Stock 1.31% up -7.56% 8.87 + Medicine, Cancer fight

+ My List
BLRX BioLineRx Ltd. - American Depositary Shares -7.34% down -6.42% -0.92 + Medicine, Cancer fight

+ My List
BNGO Bionano Genomics, Inc. - Common Stock 1.98% up -10.04% 12.02 + Medicine, Cancer fight, Gene and cell


Last highlighted: Bionano Genomics Acquires Diagnostics Services Provider Lineagen, Inc. to Accelerate Clinical Adoption of Saphyr for Digital Cytogenetics https://t.co/Q8ywclbV2i
+ My List
BNGOW Bionano Genomics, Inc. - Warrant -11.01% -11.01% 0 + Cancer fight, Medicine, Gene and cell

+ My List
BNR Burning Rock Biotech Limited - American Depositary Shares -6.26% up -9.09% 2.83 + Country: China, Cancer fight, Medicine

+ My List
BPTH Bio-Path Holdings, Inc. - Common Stock 4.1% up -7.14% 11.24 + Cancer fight, Medicine

+ My List
BYSI BeyondSpring, Inc. - Ordinary Shares 2.37% up -12.29% 14.66 + Cancer fight, Biopharma, Medicine, Immunology


Last highlighted: Form 6-K (report of foreign issuer [rules 13a-16 and 15d-16]) filed with the SEC $BYSI https://t.co/AH1YS5LVCR
+ My List
CALA Calithera Biosciences, Inc. - Common Stock -10% -10% 0 + Medicine, Cancer fight

+ My List
CBLI Cleveland BioLabs, Inc. - Common Stock 0.00% 0 + Cancer fight

+ My List
CCXI ChemoCentryx, Inc. - Common Stock -7.46% down -7.25% -0.21 + Biopharma, Cancer fight, Immunology, Medicine


Last highlighted: #CCXI SEC report: ChemoCentryx, Inc. Current report, items 7.01, 8.01, and 9.01
+ My List
CELC Celcuity Inc. - Common Stock 0.94% up -7.6% 8.54 + Cancer fight, Medicine


Last highlighted: #CELC SEC report: Celcuity Inc. Statement of acquisition of beneficial ownership by individuals
SEC Filing Form SC 13G filed by Celcuity Inc. -- SEC File Number 211081754
+ My List
CGIX Cancer Genetics, Inc. - Common Stock 0.00% 0 + Cancer fight, Medicine

+ My List
CKPT Checkpoint Therapeutics, Inc. - Common Stock up -9.57% 9.57 + Cancer fight, Medicine

+ My List
CLDX Celldex Therapeutics, Inc. - Common Stock 3.31% up -10.72% 14.03 + Cancer fight, Immunology, Medicine


Last highlighted: #CLDX SEC report: Celldex Therapeutics, Inc. Current report, items 2.02 and 9.01
SEC Filing Form 8-K filed by Celldex Therapeutics, Inc. -- SEC File Number 211148052
+ My List
CLLS Cellectis S.A. - American Depositary Shares 3.9% down 7.56% -3.66 + Biopharma, Medicine, Cancer fight

+ My List
CLRB Cellectar Biosciences, Inc. - Common Stock -6.93% up -7.84% 0.91 + Medicine, Biopharma, Cancer fight


Last highlighted: #CLRB SEC report: Cellectar Biosciences, Inc. Current report, items 7.01 and 9.01
SEC Filing Form 8-K filed by Cellectar Biosciences, Inc. -- SEC File Number 211087932
+ My List
CLSN Celsion Corporation - Common Stock 7.84% up 3.92% 3.92 + Cancer fight, Medicine

+ My List
CMPI Checkmate Pharmaceuticals, Inc. - Common Stock -7.96% down -6.57% -1.39 + Cancer fight, Medicine, Pharmaceutical


Last highlighted: #CMPI SEC report: Checkmate Pharmaceuticals, Inc. Current report, items 7.01 and 9.01
SEC Filing Form 8-K filed by Checkmate Pharmaceuticals, Inc. -- SEC File Number 211142205
+ My List
CNST Constellation Pharmaceuticals, Inc. - Common Stock 65.42% down 65.56% -0.14 + Cancer fight, Medicine, Pharmaceutical

+ My List
CRDF Cardiff Oncology, Inc. - Common Stock -2.76% down 10.59% -13.35 + Cancer fight, Medicine


Last highlighted: #CRDF SEC report: Cardiff Oncology, Inc. Current report, items 2.02 and 9.01
SEC Filing Form 8-K filed by Cardiff Oncology, Inc. -- SEC File Number 211148042
+ My List
CRIS Curis, Inc. - Common Stock 7.67% 7.67% 0 + Cancer fight, Medicine

+ My List
CSTL Castle Biosciences, Inc. - Common stock -0.19% up -9.7% 9.51 + Cancer fight, Medicine

+ My List
CTMX CytomX Therapeutics, Inc. - Common Stock -0.97% down 7.3% -8.27 + Biopharma, Cancer fight, Disease: Oncology
- Bad infrastructure
+ My List
CUE Cue Biopharma, Inc. - Common Stock 0.46% up -8.54% 9 + Biopharma, Immunology, Cancer fight

+ My List
CYCCP Cyclacel Pharmaceuticals, Inc. - 6% Convertible Preferred Stock down 8.63% -8.63 + Cancer fight, Medicine, Biopharma


Last highlighted: Filing Alert, FORM 8-K [Press/News Current Report] available. $CYCC $CYCCP #CyclacelPharmaceuticals, Inc. https://t.co/wcEcOgiN2c
+ My List
DCTH Delcath Systems, Inc. - Common Stock -7.01% down -5.1% -1.91 + Cancer fight, Medicine, Disease: Liver


Last highlighted: #DCTH SEC report: DELCATH SYSTEMS, INC. Notice of Effectiveness
+ My List
DMTK DermTech, Inc. - Common Stock -0.55% up -7.32% 6.77 + Medicine, Cancer fight, Skin


Last highlighted: #DMTK SEC report: DermTech, Inc. Initial statement of beneficial ownership of securities
SEC Filing Form 3 filed by DermTech, Inc. -- SEC File Number
+ My List
DTIL Precision BioSciences, Inc. - Common Stock -7.71% -7.71% 0 + Cancer fight, Gene and cell, Food

+ My List
ENOB Enochian Biosciences, Inc. - Common Stock 1.37% up -7.77% 9.14 + Disease: Infectious, Cancer fight, Immunology, Medicine

+ My List
EPIX ESSA Pharma Inc. - Common Stock -6.65% up -8.02% 1.37 + Pharmaceutical , Country: Canada, Cancer fight


Last highlighted: #EPIX SEC report: ESSA Pharma Inc. [Amend] Statement of acquisition of beneficial ownership by individuals
SEC Filing Form SC 13G/A filed by ESSA Pharma Inc. -- SEC File Number 211182253
+ My List
EPZM Epizyme, Inc. - Common Stock 0.46% 0.46% 0 + Cancer fight, Gene and cell

+ My List
FATE Fate Therapeutics, Inc. - Common Stock 2.91% up -7.31% 10.22 + Cancer fight, Immunology, Medicine

+ My List
FGEN FibroGen, Inc - Common Stock 6.12% down 8.27% -2.15 + Medicine, Cancer fight, Respiratory therapies / Pulmanory

+ My List
FLDM Fluidigm Corporation - Common Stock 2.2% down 10.69% -8.49 + Life Sciences, Biology, Cancer fight, Biotechnology, RNA


Last highlighted: #FLDM SEC report: FLUIDIGM CORP Current report, items 1.01, 2.03, and 9.01
SEC Filing Form 8-K filed by FLUIDIGM CORP -- SEC File Number 211148270
+ My List
FPRX Five Prime Therapeutics, Inc. - Common Stock 0.00% 0 + Cancer fight, Medicine

+ My List
FUSN Fusion Pharmaceuticals Inc. - Common Shares 3.82% down 12.14% -8.32 + Pharmaceutical , Country: Canada, Medicine, Radiotherapy, Cancer fight

+ My List
GALT Galectin Therapeutics Inc. - Common Stock 0.47% up -7.86% 8.33 + Cancer fight, Disease: Liver, Skin, Medicine


Last highlighted: #GALT SEC report: GALECTIN THERAPEUTICS INC Current report, items 8.01 and 9.01
SEC Filing Form 8-K filed by GALECTIN THERAPEUTICS INC -- SEC File Number 211081679
+ My List
GLSI Greenwich LifeSciences, Inc. - Common stock 7.3% 7.3% 0 + Medicine, Biopharma, Cancer fight, Immunology

+ My List
GNCA Genocea Biosciences, Inc. - Common Stock -7.89% -7.89% 0 + Cancer fight, Immunology, Medicine

+ My List
GNPX Genprex, Inc. - Common Stock -3.11% up -15.27% 12.16 + Cancer fight, Disease: Oncology, Medicine


Last highlighted: $GNPX [15s. delayed] filed form 10-Q on August 13, 16:34:15 https://t.co/cEVufMKwcd
+ My List
GOVX GeoVax Labs, Inc. - Common Stock -11.18% up -13.74% 2.56 + Medicine, Cancer fight

+ My List
GRTS Gritstone Oncology, Inc. - Common Stock -5.42% up -7.13% 1.71 + Medicine, Immunology, Cancer fight

+ My List
GTH Genetron Holdings Limited - American Depositary Shares -5.59% up -8.28% 2.69 + Cancer fight, Medicine, Disease: Oncology, Country: China


Last highlighted: $GTH / Genetron Holdings Limited ADS files form 6-K https://t.co/3DehdripqL
+ My List
HCM Hutchison China MediTech Limited - American Depositary Shares -0.73% -0.73% 0 + Country: China, Medicine, Disease: Oncology, Cancer fight


Last highlighted: $HCM 📜 SEC Form 6-K filed by Hutchison China MediTech Limited https://t.co/3MQ4DYnXFz 15s delayed.
+ My List
HGEN Humanigen, Inc. - Common Stock 3.3% up -13.66% 16.96 + Biopharma, Immunology, Cancer fight, Medicine


Last highlighted: #HGEN SEC report: HUMANIGEN, INC Current report, items 7.01 and 9.01
SEC Filing Form 8-K filed by HUMANIGEN, INC -- SEC File Number 211142187
+ My List
HOOK HOOKIPA Pharma Inc. - Common Stock -6.97% up -8.61% 1.64 + Disease: Infectious, Immunology, Cancer fight, Medicine

+ My List
HTBX Heat Biologics, Inc. - Common Stock 1.55% up -11.55% 13.1 + Medicine, Cancer fight

+ My List
ICAD icad inc. - Common Stock -2.11% down 7.12% -9.23 + Medicine, Devices, Cancer fight


Last highlighted: #ICAD SEC report: ICAD INC Statement of changes in beneficial ownership of securities
SEC Filing Form 4 filed by ICAD INC -- SEC File Number
+ My List
ILMN Illumina, Inc. - Common Stock 0.35% down 9.18% -8.83 + Medicine, Gene and cell, Biology, Cancer fight, Reproductive health


Last highlighted: #ILMN SEC report: ILLUMINA, INC. Current report, items 2.02 and 9.01
SEC Filing Form 8-K filed by ILLUMINA, INC. -- SEC File Number 211148268
+ My List
IMMP Immutep Limited - American Depositary Shares -6.02% up -7.08% 1.06 + Cancer fight, Medicine

+ My List
IMNM Immunome, Inc. - Common Stock -6.44% up -7.14% 0.7 + Cancer fight, Biotechnology, Medicine, Immunology

+ My List
IMTX Immatics N.V. - Ordinary Shares 1.85% down 7.12% -5.27 + Immunology, Cancer fight, Disease: Oncology, Medicine

+ My List
INFI Infinity Pharmaceuticals, Inc. - Common Stock -3.33% up -9.09% 5.76 + Medicine, Cancer fight


Last highlighted: #INFI SEC report: INFINITY PHARMACEUTICALS, INC. Initial statement of beneficial ownership of securities
SEC Filing Form 3 filed by INFINITY PHARMACEUTICALS, INC. -- SEC File Number
+ My List
INMB INmune Bio Inc. - Common stock 7.06% 7.06% 0 + Immunology, Cancer fight, Disease: Oncology, Medicine

+ My List
IOVA Iovance Biotherapeutics, Inc. - Common Stock -6.77% up -11.38% 4.61 + Biotechnology, Gene and cell, Immunology, Cancer fight, Disease: Oncology, T cell-based


Last highlighted: #IOVA SEC report: IOVANCE BIOTHERAPEUTICS, INC. Current report, items 2.02 and 9.01
SEC Filing Form 8-K filed by IOVANCE BIOTHERAPEUTICS, INC. -- SEC File Number 211148127
+ My List
ITOS iTeos Therapeutics, Inc. - Common Stock 2.37% 2.37% 0 + Cancer fight, Biopharma, Disease: Oncology, Immunology, Medicine


Last highlighted: $ITOS 📜 iTeos Therapeutics, Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement https://t.co/fsH6i8bthL 15s delayed.
+ My List
JNCE Jounce Therapeutics, Inc. - Common Stock -4.12% up -7.12% 3 + Immunology, Cancer fight, Medicine

+ My List
KPTI Karyopharm Therapeutics Inc. - Common Stock -0.71% down 8.9% -9.61 + Cancer fight, Disease: Oncology, Pharmaceutical , Medicine


Last highlighted: #KPTI SEC report: Karyopharm Therapeutics Inc. Statement of changes in beneficial ownership of securities
SEC Filing Form 4 filed by Karyopharm Therapeutics Inc. -- SEC File Number
+ My List
KRBP Kiromic BioPharma, Inc. - Common Stock -7.43% -7.43% 0 + Biopharma, Cancer fight, Immunology, Medicine


Last highlighted: #KRBP SEC report: Kiromic Biopharma, Inc. Statement of acquisition of beneficial ownership by individuals
+ My List
KTRA Kintara Therapeutics, Inc. - Common Stock -9.62% down -7.69% -1.93 + Cancer fight, Medicine

+ My List
KURA Kura Oncology, Inc. - Common Stock -6.61% up -7.09% 0.48 + Cancer fight, Medicine


Last highlighted: #KURA SEC report: Kura Oncology, Inc. Current report, items 2.02 and 9.01
SEC Filing Form 8-K filed by Kura Oncology, Inc. -- SEC File Number 211148278
+ My List
MACK Merrimack Pharmaceuticals, Inc. - Common Stock 8.14% 8.14% 0 + Pharmaceutical , Cancer fight, Medicine

+ My List
MBRX Moleculin Biotech, Inc. - Common Stock -0.57% down 14.2% -14.77 + Biotechnology, Pharmaceutical , Medicine, Cancer fight, Disease: Infectious


Last highlighted: #MBRX SEC report: Moleculin Biotech, Inc. Statement of changes in beneficial ownership of securities
+ My List
MGNX MacroGenics, Inc. - Common Stock -4.21% up -7.32% 3.11 + Medicine, Cancer fight

+ My List
MGTA Magenta Therapeutics, Inc. - Common Stock -1.72% up -9.69% 7.97 + Gene and cell, Cancer fight, Blood, Immunology, Medicine


Last highlighted: #MGTA SEC report: Magenta Therapeutics, Inc. Notice of Effectiveness
SEC Filing Form EFFECT filed by Magenta Therapeutics, Inc. -- SEC File Number 211084159
+ My List
MNPR Monopar Therapeutics Inc. - Common Stock 3.2% down 7.83% -4.63 + Cancer fight, Medicine, Biopharma


Last highlighted: #MNPR SEC report: Monopar Therapeutics Current report, items 7.01 and 9.01
SEC Filing Form 8-K filed by Monopar Therapeutics -- SEC File Number 211138054
+ My List
MOR MorphoSys AG - American Depositary Shares -6.23% up -7.21% 0.98 + Biopharma, Medicine, Disease: Oncology, Immunology, Cancer fight

+ My List
MREO Mereo BioPharma Group plc - American Depositary Shares 7.97% 7.97% 0 + Biopharma, Cancer fight, Country: Greate Britain


Last highlighted: #MREO SEC report: Mereo Biopharma Group plc Registration statement by foreign private issuers
SEC Filing Form F-3 filed by Mereo Biopharma Group plc -- SEC File Number 211148904
+ My List
MRKR Marker Therapeutics, Inc. - Common Stock up -7.77% 7.77 + Immunology, Medicine, Cancer fight


Last highlighted: #MRKR SEC report: Marker Therapeutics, Inc. Current report, items 7.01 and 9.01
+ My List
MRSN Mersana Therapeutics, Inc. - Common Stock -5.91% up -8.03% 2.12 + Medicine, Cancer fight


Last highlighted: #MRSN SEC report: Mersana Therapeutics, Inc. Statement of changes in beneficial ownership of securities
SEC Filing Form 4 filed by Mersana Therapeutics, Inc. -- SEC File Number
+ My List
MRUS Merus N.V. - Common Shares -2.01% down 9.24% -11.25 + Cancer fight, Medicine, Country: Netherlands


Last highlighted: #MRUS SEC report: Merus N.V. Quarterly report [Sections 13 or 15(d)]
SEC Filing Form 10-Q filed by Merus N.V. -- SEC File Number 211148220
+ My List
NCNA NuCana plc - American Depositary Shares 10% 10% 0 + Cancer fight, Disease: Oncology, Medicine

+ My List
NH NantHealth, Inc. - Common Stock -8.41% -8.41% 0 + Cancer fight, Medicine
- Bad infrastructure
+ My List
NK NantKwest, Inc. - Common Stock 0.00% 0 + Cancer fight, Medicine, Immunology
- Bad infrastructure
+ My List
NRIX Nurix Therapeutics, Inc. - Common stock -6.76% up -7.3% 0.54 + Biotechnology, Cancer fight, Immunology


Last highlighted: #NRIX SEC report: Nurix Therapeutics, Inc. Current report, items 2.02 and 9.01
SEC Filing Form 8-K filed by Nurix Therapeutics, Inc. -- SEC File Number 211088020
+ My List
NVCR NovoCure Limited - Ordinary Shares 5.38% down 7.81% -2.43 + Cancer fight, Medicine

+ My List
ODT Odonate Therapeutics, Inc. - Common Stock down 21.57% -21.57 + Cancer fight, Medicine


Last highlighted: #ODT SEC report: Odonate Therapeutics, Inc. Current report, items 5.02 and 9.01
SEC Filing Form 8-K filed by Odonate Therapeutics, Inc. -- SEC File Number 211148890
+ My List
ONCR Oncorus, Inc. - Common Stock -7.31% down -6.6% -0.71 + Cancer fight, Immunology, Biotechnology


Last highlighted: #ONCR SEC report: Oncorus, Inc. Current report, items 2.02 and 9.01
SEC Filing Form 8-K filed by Oncorus, Inc. -- SEC File Number 211142316
+ My List
ONCS OncoSec Medical Incorporated - Common Stock up -9.52% 9.52 + Cancer fight, Disease: Oncology, Medicine, Immunology


Last highlighted: #ONCS SEC report: ONCOSEC MEDICAL Inc Statement of changes in beneficial ownership of securities
SEC Filing Form 4 filed by ONCOSEC MEDICAL Inc -- SEC File Number
+ My List
ONCY Oncolytics Biotech Inc. - Common Shares 7.28% 7.28% 0 + Medicine, Cancer fight, Country: Canada, Immunology


Last highlighted: $ONCY / Oncolytics Biotech files form 6-K https://t.co/G1byP6giz8
+ My List
ORIC Oric Pharmaceuticals, Inc. - Common Stock -2.11% up -12.47% 10.36 + Pharmaceutical , Medicine, Disease: Oncology, Cancer fight


Last highlighted: #ORIC SEC report: Oric Pharmaceuticals, Inc. Current report, items 8.01 and 9.01
SEC Filing Form 8-K filed by Oric Pharmaceuticals, Inc. -- SEC File Number 211078899
+ My List
PDSB PDS Biotechnology Corporation - Common Stock -3.28% up -7.1% 3.82 + Biotechnology, Immunology, Cancer fight, Disease: Oncology, Medicine


Last highlighted: RT @EdgarInsider: FORM 8-K [Press/News Current Report] recently SEC filed. $PDSB $EDGE PDS Biotechnology Corp https://t.co/FKxSQ3btJT
+ My List
PHIO Phio Pharmaceuticals Corp. - Common Stock -7% -7% 0 + Medicine, Cancer fight, Immunology


Last highlighted: #PHIO SEC report: Phio Pharmaceuticals Corp. Statement of changes in beneficial ownership of securities
SEC Filing Form 4 filed by Phio Pharmaceuticals Corp. -- SEC File Number
+ My List
PIRS Pieris Pharmaceuticals, Inc. - Common Stock -6.39% up -7.67% 1.28 + Biopharma, Respiratory therapies / Pulmanory, Medicine, Immunology, Cancer fight


Last highlighted: #PIRS SEC report: PIERIS PHARMACEUTICALS, INC. Current report, items 2.02, 7.01, and 9.01
SEC Filing Form 8-K filed by PIERIS PHARMACEUTICALS, INC. -- SEC File Number 211142334
+ My List
PMVP PMV Pharmaceuticals, Inc. - Common Stock 0.32% up -15.83% 16.15 + Medicine, Cancer fight, Pharmaceutical


Last highlighted: #PMVP SEC report: PMV Pharmaceuticals, Inc. Statement of changes in beneficial ownership of securities
SEC Filing Form 4 filed by PMV Pharmaceuticals, Inc. -- SEC File Number
+ My List
POAI Predictive Oncology Inc. - Common Stock up -7% 7 + Cancer fight, Medicine, Artificial Intelligence


Last highlighted: #POAI SEC report: Predictive Oncology Inc. Statement of changes in beneficial ownership of securities
SEC Filing Form 4 filed by Predictive Oncology Inc. -- SEC File Number
+ My List
PRLD Prelude Therapeutics Incorporated - Common Stock -3.6% up -7.91% 4.31 + Cancer fight, Medicine


Last highlighted: #PRLD SEC report: Prelude Therapeutics Inc Statement of changes in beneficial ownership of securities
SEC Filing Form 4 filed by Prelude Therapeutics Inc -- SEC File Number
+ My List
PROG Progenity, Inc. - Common Stock 10.19% 10.19% 0 + Gene and cell, Medicine, Cancer fight, Women Health


Last highlighted: #PROG SEC report: PROGENITY, INC. Initial statement of beneficial ownership of securities
SEC Filing Form 3 filed by PROGENITY, INC. -- SEC File Number
+ My List
PSTV PLUS THERAPEUTICS, Inc. - Common Stock 2% down 12% -10 + Cancer fight, Medicine, Radiotherapy


Last highlighted: #PSTV SEC report: PLUS THERAPEUTICS, INC. [Amend] Quarterly report [Sections 13 or 15(d)]
+ My List
QTRX Quanterix Corporation - Common Stock -0.06% up -7.07% 7.01 + Healthcare, Biology, Disease: Infectious, Disease: Cardiovascular, Cancer fight, Disease: Oncology


Last highlighted: #QTRX SEC report: Quanterix Corp Statement of changes in beneficial ownership of securities
SEC Filing Form 4 filed by Quanterix Corp -- SEC File Number
+ My List
RAPT RAPT Therapeutics, Inc. - Common Stock 1.67% up -14.21% 15.88 + Cancer fight, Medicine


Last highlighted: #RAPT SEC report: RAPT Therapeutics, Inc. Statement of changes in beneficial ownership of securities
SEC Filing Form 4 filed by RAPT Therapeutics, Inc. -- SEC File Number
+ My List
REPL Replimune Group, Inc. - Common Stock 2.62% 2.62% 0 + Cancer fight


Last highlighted: #REPL SEC report: Replimune Group, Inc. [Amend] Statement of changes in beneficial ownership of securities
SEC Filing Form 4/A filed by Replimune Group, Inc. -- SEC File Number
+ My List
RIGL Rigel Pharmaceuticals, Inc. - Common Stock 0.76% down 9.5% -8.74 + Medicine, Cancer fight

+ My List
RUBY Rubius Therapeutics, Inc. - Common Stock -1.35% down 7.22% -8.57 + Gene and cell, Cancer fight, Medicine

+ My List
RVMD Revolution Medicines, Inc. - Common Stock 6.34% down 8.21% -1.87 + Cancer fight, Medicine, Biotechnology

+ My List
SESN Sesen Bio, Inc. - Common Stock up -18.35% 18.35 + Cancer fight, Medicine


Last highlighted: #SESN SEC report: Sesen Bio, Inc. Current report, items 5.02 and 9.01
SEC Filing Form 8-K filed by Sesen Bio, Inc. -- SEC File Number 211102791
+ My List
SLRX Salarius Pharmaceuticals, Inc. - Common Stock 0 + Cancer fight, Biotechnology, Medicine, Pharmaceutical


Last highlighted: $SLRX 8-K Salarius Pharmaceuticals (8 Mar, 4:30pm) 📰 Salarius Announces Pricing of $20 Million Underwritten Public Offering of Common Stock https://t.co/AWdEx2wgvD #SLRX #8K #SalariusPharmaceuticals #News
+ My List
SLS SELLAS Life Sciences Group, Inc. - Common Stock 1.3% up -7.07% 8.37 + Cancer fight, Medicine


Last highlighted: SELLAS Announces Positive Follow-up Data from the Randomized Phase 2 VADIS Trial of Nelipepimut-S (NPS) in Women with Ductal Carcinoma In-Situ of the Breast https://www.sellaslifesciences.com/investors/news/News-Details/2020/SELLAS-Announces-Positive-Follow-up-Data-from-the-Randomized-Phase-2-VADIS-Trial-of-Nelipepimut-S-NPS-in-Women-with-Ductal-Carcinoma-In-Situ-of-the-Breast/default.aspx
+ My List
SNSS Sunesis Pharmaceuticals, Inc. - Common Stock 0.00% 0 + Medicine, Biopharma, Cancer fight

+ My List
SONN Sonnet BioTherapeutics Holdings, Inc. - Common Stock -45.05% down -44.14% -0.91 + Cancer fight, Biology, Medicine

+ My List
SRNE Sorrento Therapeutics, Inc. - Common Stock 7.16% up 6.29% 0.87 + Pain fight, Cancer fight, Medicine

+ My List
STRO Sutro Biopharma, Inc. - Common Stock 0.68% up -10.83% 11.51 + Cancer fight, Medicine

+ My List
SURF Surface Oncology, Inc. - Common Stock -4.16% up -8.05% 3.89 + Cancer fight, Immunology, Medicine


Last highlighted: #SURF SEC report: Surface Oncology, Inc. Current report, items 5.02 and 9.01
SEC Filing Form 8-K filed by Surface Oncology, Inc. -- SEC File Number 211078938
+ My List
SYRS Syros Pharmaceuticals, Inc. - common stock -6.62% up -12.25% 5.63 + Gene and cell, Medicine, Cancer fight

+ My List
TARA Protara Therapeutics, Inc. - Common Stock 8.95% 8.95% 0 + Cancer fight, Medicine

+ My List
TCON TRACON Pharmaceuticals, Inc. - Common Stock 7.2% 7.2% 0 + Pharmaceutical , Cancer fight, Medicine, Biopharma, Disease: Oncology

+ My List
TCRR TCR2 Therapeutics Inc. - Common Stock -7.06% up -7.73% 0.67 + Cancer fight, Medicine

+ My List
THTX Theratechnologies Inc. - Common Shares -2.17% down 11.67% -13.84 + Cancer fight, Biopharma, Medicine

+ My List
TRIL Trillium Therapeutics Inc. - Common Shares 189.49% down 189.66% -0.16999999999999 + Country: Canada, Cancer fight, Disease: Oncology, Immunology


Last highlighted: #TRIL SEC report: Trillium Therapeutics Inc. Statement of changes in beneficial ownership of securities
SEC Filing Form 4 filed by Trillium Therapeutics Inc. -- SEC File Number
+ My List
TTOO T2 Biosystems, Inc. - Common Stock -7% down -6% -1 + Medicine, Cancer fight


Last highlighted: #TTOO SEC report: T2 Biosystems, Inc. Statement of changes in beneficial ownership of securities
SEC Filing Form 4 filed by T2 Biosystems, Inc. -- SEC File Number
+ My List
TYME Tyme Technologies, Inc. - Common Stock 4.67% down 12.15% -7.48 + Cancer fight, Medicine


Last highlighted: #TYME SEC report: TYME TECHNOLOGIES, INC. Statement of changes in beneficial ownership of securities
SEC Filing Form 4 filed by TYME TECHNOLOGIES, INC. -- SEC File Number
+ My List
VBLT Vascular Biogenics Ltd. - Ordinary Shares -8.12% down -6.09% -2.03 + Country: Israel, Biopharma, Cancer fight, Medicine

+ My List
VERU Veru Inc. - Common Stock -3.44% down 13.76% -17.2 + Cancer fight, Medicine


Last highlighted: Veru, Inc. (VERU) CEO Mitchell Steiner on Q4 2020 Results - Earnings Call Transcript
+ My List
VRAY ViewRay, Inc. - Common Stock 5.65% down 8.82% -3.17 + Cancer fight, Radiotherapy, Medicine


Last highlighted: #VRAY SEC report: ViewRay, Inc. Current report, items 2.02, 7.01, and 9.01
SEC Filing Form 8-K filed by ViewRay, Inc. -- SEC File Number 211148242
+ My List
VSTM Verastem, Inc. - Common Stock 8.19% up 5.26% 2.93 + Biopharma, Cancer fight, Medicine


Last highlighted: #VSTM SEC report: Verastem, Inc. Automatic shelf registration statement of securities of well-known seasoned issuers
SEC Filing Form S-3ASR filed by Verastem, Inc. -- SEC File Number 211136620
+ My List
XBIO Xenetic Biosciences, Inc. - Common Stock -0.73% down 7.03% -7.76 + Biopharma, Cancer fight, Disease: Oncology, Medicine

+ My List
XFOR X4 Pharmaceuticals, Inc. - Common Stock 6.7% down 7.66% -0.96 + Cancer fight, Medicine, Pharmaceutical


Last highlighted: #XFOR SEC report: X4 Pharmaceuticals, Inc Current report, item 2.02
SEC Filing Form 8-K filed by X4 Pharmaceuticals, Inc -- SEC File Number 211138073
+ My List
YMAB Y-mAbs Therapeutics, Inc. - Common Stock -6.29% up -7.09% 0.8 + Biopharma, Cancer fight, Medicine


Last highlighted: #YMAB SEC report: Y-mAbs Therapeutics, Inc. Current report, items 2.02 and 9.01
SEC Filing Form 8-K filed by Y-mAbs Therapeutics, Inc. -- SEC File Number 211148421
+ My List
ZIOP ZIOPHARM Oncology Inc - Common Stock -8.18% -8.18% 0 + T cell-based, Cancer fight, Disease: Oncology, Immunology, Medicine

+ My List
ZNTL Zentalis Pharmaceuticals, Inc. - common stock -7.19% down -6% -1.19 + Cancer fight, Biology, Pharmaceutical , Medicine


Last highlighted: #ZNTL SEC report: Zentalis Pharmaceuticals, Inc. Statement of changes in beneficial ownership of securities
SEC Filing Form 4 filed by Zentalis Pharmaceuticals, Inc. -- SEC File Number
+ My List
BCTX BriaCell Therapeutics Corp. - Common Shares 7.07% up 3.41% 3.66 + Cancer fight, Immunology, Medicine, Disease: Oncology


Last highlighted: #BCTX SEC report: BriaCell Therapeutics Corp. Report of foreign issuer [Rules 13a-16 and 15d-16]
SEC Filing Form 6-K filed by BriaCell Therapeutics Corp. -- SEC File Number 211182540
+ My List
BOLT Bolt Biotherapeutics, Inc. - Common Stock -7.24% down -4.83% -2.41 + Immunology, Cancer fight, Disease: Oncology, Medicine

+ My List
ENVB Enveric Biosciences, Inc. - Common Stock -10.68% -10.68% 0 + Biotechnology, Cancer fight, Medicine, Cannabis, Disease: Oncology


Last highlighted: #ENVB SEC report: Enveric Biosciences, Inc. Notice of Effectiveness
SEC Filing Form EFFECT filed by Enveric Biosciences, Inc. -- SEC File Number 211084155
+ My List
EVAX Evaxion Biotech A/S - American Depositary Share -7.14% down -5.99% -1.15 + Cancer fight, Disease: Oncology, Immunology, Medicine, Biotechnology, Biology


Last highlighted: #EVAX SEC report: Evaxion Biotech A/S Report of foreign issuer [Rules 13a-16 and 15d-16]
SEC Filing Form 6-K filed by Evaxion Biotech A/S -- SEC File Number 211078935
+ My List
FSTX F-star Therapeutics, Inc. - Common Stock -8.33% -8.33% 0 + Immunology, Medicine, Cancer fight, Disease: Oncology


Last highlighted: #FSTX SEC report: F-star Therapeutics, Inc. Statement of changes in beneficial ownership of securities
SEC Filing Form 4 filed by F-star Therapeutics, Inc. -- SEC File Number
+ My List
GTBP GT Biopharma, Inc. - Common Stock -6.25% up -8.75% 2.5 + Biopharma, Medicine, Disease: Oncology, Immunology, Cancer fight


Last highlighted: #GTBP SEC report: GT Biopharma, Inc. Notification of inability to timely file Form 10-Q or 10-QSB
SEC Filing Form NT 10-Q filed by GT Biopharma, Inc. -- SEC File Number 211181131
+ My List
LIXT Lixte Biotechnology Holdings, Inc. - Common Stock -9.26% -9.26% 0 + Biotechnology, Cancer fight, Disease: Oncology, Medicine


Last highlighted: #LIXT SEC report: LIXTE BIOTECHNOLOGY HOLDINGS, INC. Current report, item 5.07
SEC Filing Form 8-K filed by LIXTE BIOTECHNOLOGY HOLDINGS, INC. -- SEC File Number 211083663
+ My List
OCX OncoCyte Corporation - Common Stock -7.28% down -4.85% -2.43 + Cancer fight, Diagnosing, Medicine


Last highlighted: #OCX SEC report: OncoCyte Corp Current report, items 2.02 and 9.01
SEC Filing Form 8-K filed by OncoCyte Corp -- SEC File Number 211160996
+ My List
PPBT Purple Biotech Ltd. - American Depositary Shares 8.5% up 7.96% 0.54 + Country: Israel, Cancer fight, Disease: Oncology

+ My List
PRTG Portage Biotech Inc. - Common Stock 8.65% up 2.77% 5.88 + Country: Canada, Immunology, Cancer fight, Disease: Oncology

+ My List
SBTX Silverback Therapeutics, Inc. - Common Stock -7.44% -7.44% 0 + Cancer fight, Disease: Oncology, Disease: Infectious, Medicine

+ My List
SCPS Scopus BioPharma Inc. - Common Stock -6.67% up -7.33% 0.66 + Immunology, Cancer fight, Medicine, Disease: Oncology, Biopharma


Last highlighted: Alert [Quarterly Report] / Form 10-Q filed with the SEC $SCPS Scopus BioPharma Inc. Scopus BioPharma Inc https://t.co/lmBK4v1IJB
+ My List
VOR Vor Biopharma Inc. - Common Stock 9.78% 9.78% 0 + Biopharma, Medicine, Cancer fight, Disease: Oncology

+ My List
IKNA Ikena Oncology, Inc. - Common Stock -11% -11% 0 + Cancer fight, Disease: Oncology, Medicine

+ My List
LVTX LAVA Therapeutics N.V. - Ordinary Shares -7.05% down -4.19% -2.86 + T cell-based, Cancer fight, Medicine, Disease: Oncology

+ My List


We do not provide financial advice. All displayed data is the result of experiments, and a subjective assessment. All decisions that will be made based on this data are made at your own risk. Thank you for understanding.